Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibody drug conjugates
Biotech
BigHat, Synaffix collab outfits AI science with ADC tech
BigHat is adding Synaffix’s ADC tech to its wardrobe, pairing the science with its antibody design platform to tailor a next-gen ADC pipeline.
Gabrielle Masson
Nov 4, 2024 11:07am
AZ outlines AI-enabled TROP2 biomarker strategy for Daiichi ADC
Sep 8, 2024 12:22pm
FDA allows BioNTech-MediLink ADC trial to resume at lower doses
Aug 19, 2024 8:45am
ArriVent licenses ADC from $100M biobuck deal with Aarvik
Aug 15, 2024 8:58am
Exelixis drops ADC after deciding it's no match for Tivdak
Aug 7, 2024 5:22am
OS Therapies refiles $6M IPO to fund HER2 drug, preclinical ADCs
Aug 1, 2024 5:18am
